Advertisement

Reconsidering the Gatekeeper Paradigm for Percutaneous Coronary Intervention in Stable Coronary Disease Management

      Major randomized clinical trials over the last decade support the role of optimal medical therapy for the initial management approach for patients with stable coronary artery disease (CAD), whereas percutaneous coronary intervention (PCI) ought to be reserved for patients with persistent symptoms despite optimal medical therapy. Likewise, several studies have continued to demonstrate the superiority of coronary artery bypass grafting surgery over PCI in many patients with extensive multivessel CAD, especially those with diabetes. Nevertheless, the decision-making paradigm for patients with stable CAD often continues to propagate the upfront use of “ad hoc PCI” and disadvantages alternative therapeutic approaches. In our editorial, we discuss how multiple systemic and interpersonal factors continue to favor early revascularization with PCI in stable patients. We discuss whether the interventional cardiologist can be an unbiased “gatekeeper” for the use of PCI or whether other physicians should also be involved with the patient in decision-making. Finally, we offer suggestions that can redefine the gatekeeper role to facilitate an evidence-based approach that embraces shared decision-making.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.M.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini G.B.
        • Weintraub W.S.
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • The BARI 2D Study Group
        A randomized trial of therapies for type 2 diabetes and coronary artery disease.
        N Engl J Med. 2009; 360: 2503-2515
        • Mohr F.W.
        • Morice M.C.
        • Kappetein A.P.
        • Feldman T.E.
        • Stahle E.
        • Colombo A.
        • Mack M.J.
        • Holmes Jr, D.R.
        • Morel M.A.
        • Van Dyck N.
        • Houle V.M.
        • Dawkins K.D.
        • Serruys P.W.
        Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
        Lancet. 2013; 381: 629-638
        • Milojevic M.
        • Head S.J.
        • Parasca C.A.
        • Serruys P.W.
        • Mohr F.W.
        • Morice M.C.
        • Mack M.J.
        • Stahle E.
        • Feldman T.E.
        • Dawkins K.D.
        • Colombo A.
        • Kappetein A.P.
        • Holmes Jr, D.R.
        Causes of death following PCI versus CABG in complex CAD: 5-year follow-up of sYNTAX.
        J Am Coll Cardiol. 2016; 67: 42-55
        • Mancini G.B.
        • Farkouh M.E.
        • Brooks M.M.
        • Chaitman B.R.
        • Boden W.E.
        • Vlachos H.
        • Hartigan P.M.
        • Siami F.S.
        • Sidhu M.S.
        • Bittner V.
        • Frye R.
        • Fuster V.
        Medical treatment and revascularization options in patients with type 2 diabetes and coronary disease.
        J Am Coll Cardiol. 2016; 68: 985-995
        • Fihn S.D.
        • Gardin J.M.
        • Abrams J.
        • Berra K.
        • Blankenship J.C.
        • Dallas A.P.
        • Douglas P.S.
        • Foody J.M.
        • Gerber T.C.
        • Hinderliter A.L.
        • King 3rd, S.B.
        • Kligfield P.D.
        • Krumholz H.M.
        • Kwong R.Y.
        • Lim M.J.
        • Linderbaum J.A.
        • Mack M.J.
        • Munger M.A.
        • Prager R.L.
        • Sabik J.F.
        • Shaw L.J.
        • Sikkema J.D.
        • Smith Jr, C.R.
        • Smith Jr, S.C.
        • Spertus J.A.
        • Williams S.V.
        2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2012; 60: e44-e164
        • Patel M.R.
        • Calhoon J.H.
        • Dehmer G.J.
        • Grantham J.A.
        • Maddox T.M.
        • Maron D.J.
        • Smith P.K.
        ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2017; 69: 2212-2241
        • Goff S.L.
        • Mazor K.M.
        • Ting H.H.
        • Kleppel R.
        • Rothberg M.B.
        How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis.
        JAMA Intern Med. 2014; 174: 1614-1621
        • Rothberg M.B.
        • Sivalingam S.K.
        • Kleppel R.
        • Schweiger M.
        • Hu B.
        • Sepucha K.R.
        Informed decision making for percutaneous coronary intervention for stable coronary disease.
        JAMA Intern Med. 2015; 175: 1199-1206